Mylan Labs Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Mylan Labs

MYL 15.86

0.0%

Nov 19 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: StockDoc who wrote (308)	5/5/1998 9:58:00 PM
From: B. W. Lewis	Read Replies (2) of 384

StockDoc While you stated that you are not particularly excited with drug deliver companies, you should probably take a good look @ ELN as an alternative method of investing in EMIS. They have a substantial interest in EMIS and have licensed some of their technology. In addition, they provide you with cushion of other products, technologies and marketings that smaller companies just don't have. ELN gives you a history of solid earnings growth (30-40%per annum) with the demonstrated ability to bring products to the market. I should disclose that I hold a substantial position in ELN and remind you that the advice you get here and on the web in general is probably worth just what you paid for it. BWL P.S. as a sidelight ELN was founded by one of the founders of MYL

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next